NewAmsterdam Pharma Co N.V. (NAMS) Reports Material Event to SEC
Filing Details NewAmsterdam Pharma Co N.V. (NASDAQ:NAMS) filed a Form 8-K with the Securities and Exchange Commission on July 24, 2026, disclosing a material event. Market Context…
Read more
